Pursuant to circular no. CIR/CFD/CMDI/27/2019 dated February 08, 2019, issued by the securities and Exchange Board of India, for the purpose of compliance with Regulation 24A of SEBI (Listing ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI's Regulation 24A. The report, issued by Practicing Company Secretary Ms. Girija Nagvekar, confirms that the company has fully complied with all applicable SEBI regulations, circulars, and guidelines during the review period. No deviations, penalties, or non-compliance issues were reported across areas including secretarial standards, insider trading, related party transactions, subsidiary disclosures, and corporate governance policies. The report notes that BSE had previously waived a fine the company received for a Regulation 17(1) LODR non-compliance in the quarter ended December 2023.
This is a routine regulatory filing that shows the company is in good standing on compliance matters, with no new penalties or regulatory actions. Investors can take comfort that governance and disclosure practices are intact, though the report carries no direct financial or stock price implications.